OcuCure Therapeutics Overview

  • Founded
  • 2005
Founded
  • Status
  • Out of Business
  • Employees
  • 4
Employees
  • Latest Deal Type
  • Out of Business

OcuCure Therapeutics General Information

Description

Developer of topical eye drops designed to treat age-related macular degeneration and diabetic retinopathy diseases. The company's drops penetrate all the way back to the retina at clinically significant concentrations without any toxic effects, enabling patients to reduce and prevent vision loss caused by eye diseases.

Contact Information

Website
www.ocucure.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
  • 15 East Salem Avenue
  • Suite 201
  • Roanoke, VA 24011
  • United States
+1 (540) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

OcuCure Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Out of Business 01-Jul-2019 00.000 Completed Out of Business
9. Later Stage VC 04-May-2017 00000 00.000 Completed Generating Revenue
8. Later Stage VC 06-Oct-2015 00000 00.000 Completed Generating Revenue
7. Later Stage VC 26-Feb-2014 00000 00.000 Completed Generating Revenue
6. Later Stage VC 01-Jul-2013 00000 00.000 Completed Generating Revenue
5. Later Stage VC 21-Jun-2011 00000 00.000 Completed Generating Revenue
4. Early Stage VC 17-Jun-2010 00000 00.000 Completed Startup
3. Seed Round 07-Feb-2008 00000 00.000 Completed Startup
2. Seed Round 05-Nov-2007 $781K $2.28M Completed Startup
1. Seed Round 03-Aug-2006 $1.5M $1.5M Completed Startup
To view OcuCure Therapeutics’s complete valuation and funding history, request access »

OcuCure Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of topical eye drops designed to treat age-related macular degeneration and diabetic retinopathy diseases. The
Pharmaceuticals
Roanoke, VA
4 As of 2015
00.000
00000000 00 00.000

000 0000

tate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proide
0000 000000000
Bresso, Italy
0000 As of 0000
000.00
000000000 000.00

00 00000

cididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamc
000000000000000
Amman, Jordan
0000 As of 0000
0000
0000000 0000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OcuCure Therapeutics Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
The Zambon Group Private Debt Financed Bresso, Italy 0000 000.00 000000000 000.00
00 000000 00000000 Private Equity-Backed Amman, Jordan 0000 0000 0000000 0000 0000
000000000 00000000 Formerly VC-backed Tarrytown, NY 0000 00000 00000000000 00000
0000000000 0000000 Corporation San Francisco, CA 000 000000&0
000 00000000(00000 Corporation Cambridge, MA 000 000.00 00000000 000.00
You’re viewing 5 of 7 competitors. Get the full list »

OcuCure Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial